Info Sheet
Nonclinical Considerations for Cell & Gene Therapies
February 22, 2022
SOT 2019 -- Brian and Paul explore advanced therapies definitions, preclinical study and regulatory safety considerations, analytical design and validation strategies, biodistribution studies and data integrity, titre assays, CMC considerations and phase-appropriate validations for preclinical cell and gene therapies.